EMBC - Embecta Corp. -  [ ]

Ticker Details
Embecta Corp.
IPO Date: April 1, 2022
Sector: Healthcare
Industry: Drug Manufacturers - Specialty and Generic
Market Cap: $188.66M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.43 | 2.42%
Avg Daily Range (30 D): $0.07 | 2.32%
Avg Daily Range (90 D): $0.19 | 2.91%
Institutional Daily Volume
Avg Daily Volume: .56M
Avg Daily Volume (30 D): 1.61M
Avg Daily Volume (90 D): 1.57M
Trade Size
Avg Trade Size (Sh.): 67
Avg Trade Size (Sh.) (30 D): 118
Avg Trade Size (Sh.) (90 D): 108
Institutional Trades
Total Institutional Trades: 1,594
Avg Institutional Trade: $2.16M
Avg Institutional Trade (30 D): $1.79M
Avg Institutional Trade (90 D): $1.5M
Avg Institutional Trade Volume: .12M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.34M
Avg Closing Trade (30 D): $1.93M
Avg Closing Trade (90 D): $1.6M
Avg Closing Volume: 137.64K
 
News
Jul 7, 2026 @ 10:30 PM
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Embecta ...
Source: Rosen Law Firm
Jul 7, 2026 @ 4:00 PM
Bronstein, Gewirtz & Grossman LLC Urges Embecta Co...
Source: Bronstein, Gewirtz & Grossman Llc
Jul 6, 2026 @ 9:20 PM
Embecta Corp. (EMBC) Faces Securities Class Action...
Source: Hagens Berman
Jul 5, 2026 @ 1:26 PM
EMBC CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Rem...
Source: Faruqi & Faruqi, Llp
Jul 4, 2026 @ 11:01 AM
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages E...
Source: Rosen Law Firm
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $1.92 $-.07 $.75
Diluted EPS $1.89 $-.07 $.74
Revenue $1.04B $221.8M $261.2M
Gross Profit $645.1M $127.8M $161.7M
Net Income / Loss $111.9M $-4.1M $44.1M
Operating Income / Loss $268.8M $35M $83.3M
Cost of Revenue $397.4M $94M $99.5M
Net Cash Flow $-22.5M $-10.9M $-24.9M
PE Ratio